View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
December 31, 2021updated 10 Jan 2022 11:56am

Big data deals in clinical trial operations increased in H1

Big data related deals made up 1.7% of all deals announced in the clinical trial operations sector in the first six months of 2021.

By Saywah Mahmood

Big data related deals made up 1.7% of all deals announced in the clinical trial operations sector in the first six months of 2021.

This represents an increase from the figure of 1.3% in the last six months of 2020 and a decrease from 2.2% in the first six months of 2020.

GlobalData’s deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.

In the first six months of 2021, the overall number of announced deals in the clinical trial operations sector decreased by 9.9%, from the last six months of 2020.

GlobalData's thematic approach to sector activity seeks to group key company information on investments to see which industries are best placed to deal with any issues they may encounter.

These themes, of which big data is one, are best thought of as "any issue that keeps a CEO awake at night", and by tracking them, it becomes possible to ascertain which companies are leading the way on specific issues and which ones have some work to do.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena